The Sam Altman-backed longevity biotech company is upping the dose of its experimental Alzheimer's drug in clinical trials.

Source: [Business Insider](https://www.businessinsider.com/retro-biotech-testing-higher-doses-of-rtr-242-alzheimers-drug-2026-8)

Sponsored